| Literature DB >> 29738462 |
Yoshie Saito1, Natsuko Murata2, Teruyuki Noma3, Hiroyuki Itoh4, Mitsunori Kayano5, Kimihide Nakamura6,7, Tadasu Urashima8.
Abstract
A previous in vivo study with rats suggested that a special milk protein drink manufactured using an acidification procedure to suppress the aggregation of milk proteins was absorbed quickly after feeding. We performed a randomized, double-blind, placebo-controlled, repeated-measure crossover study to investigate the short-term effects on cognitive performance in 29 healthy young adult men after they consumed this drink in the morning. After an overnight fast, subjects were tested for performance in the Uchida⁻Kraepelin serial arithmetic test and the Stroop test as well as for subjective feeling, body temperature, and heart rate variability before and after consumption of either the acidified milk protein drink or an isoenergetic placebo drink. Subjects showed a significant improvement in performance in the Uchida⁻Kraepelin test, the primary outcome measured, when they consumed the acidified milk protein drink compared with the placebo control condition. In addition, consumption of the acidified milk protein drink, compared with the placebo control, was associated with increases in vagally-mediated heart rate variability indices which, from recent theoretical perspectives, may reflect a higher ability to modulate cognitive and behavioral processes. There was no significant difference in subjective feelings and body temperature between the test drink conditions. These data suggest that consumption of the acidified milk protein drink may improve cognitive performance, with possible involvement of physiological systems that regulate cognition and behavior.Entities:
Keywords: clinical study; cognitive performance; heart rate variability; milk protein
Mesh:
Substances:
Year: 2018 PMID: 29738462 PMCID: PMC5986454 DOI: 10.3390/nu10050574
Source DB: PubMed Journal: Nutrients ISSN: 2072-6643 Impact factor: 5.717
Composition of the 430 mL of test drinks.
| Acidified Milk Protein Drink | Placebo Drink | |
|---|---|---|
| Basic ingredients (%) 1 | ||
| Milk protein 2 | 4.4 | |
| Glucose 3 | 4.6 | 8.5 |
| Trehalose 4 | 1.0 | 1.0 |
| Fermented cellulose 5 | 0.05 | |
| Pectin 6 | 0.1 | |
| Soybean polysaccharide 7 | 0.45 | 0.45 |
| Citric acid 8 | 0.32 | 0.13 |
| Malic acid 9 | 0.27 | 0.11 |
| Sodium citrate 10 | 0.27 | |
| Vitamin B6 11 | 0.00019 | 0.00019 |
| Water | 88.7 | 89.0 |
| Nutrient (g) | ||
| Carbohydrate | 28 | 42 |
| Protein | 16 | 0 |
| Fat | 0.3 | 0.9 |
| Energy (kcal) | 176 | 176 |
1 Other than basic ingredients, both drinks contained 0.05% mixture of flavors, and the milk protein drink contained a mixture of sweeteners (sucralose and acesulfame K) at a concentration of 0.012% to obtain a similar taste and flavor. The placebo drink contained emulsified flavor at a concentration of 0.5% to obtain a cloudy color similar to that of the milk protein drink. The milk protein drink had a defoaming agent added to a concentration of 0.05% to dissolve the milk protein. Both drinks were adjusted to have the same pH; 2 milk protein concentrate-80 (Idaho Milk Products, Inc., Jerome, ID, USA); 3 glucose (San-ei Sucrochemical Co., Ltd., Aichi, Japan); 4 trehalose (Hayashibara Co., Ltd., Okayama, Japan); 5 fermented cellulose (San-Ei Gen F.F.I., Inc., Tokyo, Japan); 6 pectin AYD5110SB (Unitec Foods Co., Ltd., Tokyo, Japan); 7 soybean polysaccharide (San-Ei Gen F.F.I., Inc., Tokyo, Japan); 8 citric acid (Iwata Chemical Co., Ltd., Shizuoka, Japan); 9 DL-malic acid (Fuso Chemical Co., Ltd., Osaka, Japan); 10 risodium citrate (Iwata Chemical Co., Ltd., Shizuoka, Japan); 11 pyridoxine hydrochloride (Kongo Yakuhin Co., Ltd., Toyama, Japan).
Figure 1Schedule of the test session. After the fitting of the electrocardiogram (ECG) recorder and taking the compliance questionnaire, subjects underwent a baseline assessment: they recorded their subjective feelings and had their body temperature taken, practiced taking the Uchida–Kraepelin test (UKT) and the Stroop test, then they took the UKT and the Stroop test. Each subject then ingested the test drink, and repeated postprandial measurements were taken within the next 120 min. ECG was recorded throughout the test session.
Figure 2Flow of subjects through the study.
Figure 3The numbers of correct answers in the UKT in protein or placebo drink condition: (a) increments from the baseline; (b) the net incremental area under the curve (niAUC). Data are represented as means ± standard errors. * Significantly different from Placebo, p < 0.05. n = 29.
Figure 4Heart rate variability (HRV) indices during the UKT in protein or placebo drink condition: (a) increment from the baseline of root mean squared successive differences (RMSSD); (b) the niAUC of RMSSD; (c) increment from the baseline of high-frequency power (HF); (d) the niAUC of HF. Data are represented as means ± standard errors. * Significantly different from Placebo, p < 0.05. n = 19.